Literature DB >> 1722802

Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance.

K Sato1, T Nakae.   

Abstract

In order to understand high and broad antibiotic resistance of Acinetobacter calcoaceticus, the outer membrane permeability was studied. The permeability coefficients of zwitterionic cephalosporins in the intact cell outer membrane were 0.14-1.12 x 10(-4) cm3/min/mg protein. These values were two to seven times lower than the permeability coefficients of the same beta-lactams in the outer membrane of Pseudomonas aeruginosa. The diffusion rates of carbapenems and zwitterionic cephalosporins into liposomes containing purified outer membrane appeared to be about 1-3%, that of the Escherichia coli B outer membrane. These results indicate that the outer membrane of A. calcoaceticus acts as a substantial barrier against the penetration of these antibiotics. About 80 times of the A. calcoaceticus outer membrane was needed in the liposome compared with E. coli B to show the same extent of saccharide permeability. Two minor outer membrane proteins (less than 5% of total outer membrane protein) were identified to be the porins. These results suggest that one of the causes for the high antibiotic resistance of A. calcoaceticus is attributable to the presence of a small number of small-sized porins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722802     DOI: 10.1093/jac/28.1.35

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  33 in total

1.  Channel formation by CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii.

Authors:  Axel Siroy; Virginie Molle; Christelle Lemaître-Guillier; David Vallenet; Martine Pestel-Caron; Alain J Cozzone; Thierry Jouenne; Emmanuelle Dé
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

2.  The structure of a doripenem-bound OXA-51 class D β-lactamase variant with enhanced carbapenemase activity.

Authors:  Cynthia M June; Taylor J Muckenthaler; Emma C Schroder; Zachary L Klamer; Zdzislaw Wawrzak; Rachel A Powers; Agnieszka Szarecka; David A Leonard
Journal:  Protein Sci       Date:  2016-09-26       Impact factor: 6.725

3.  Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii.

Authors:  Rajbharan Yadav; Cornelia B Landersdorfer; Roger L Nation; John D Boyce; Jürgen B Bulitta
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

4.  Activity of the investigational fluoroquinolone finafloxacin against ciprofloxacin-sensitive and -resistant Acinetobacter baumannii isolates.

Authors:  Paul G Higgins; Will Stubbings; Hilmar Wisplinghoff; Harald Seifert
Journal:  Antimicrob Agents Chemother       Date:  2010-01-25       Impact factor: 5.191

Review 5.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

6.  Cloning and functional analysis of the gene encoding the 33- to 36-kilodalton outer membrane protein associated with carbapenem resistance in Acinetobacter baumannii.

Authors:  Maria del Mar Tomás; Alejandro Beceiro; Astrid Pérez; David Velasco; Rita Moure; Rosa Villanueva; Jesús Martínez-Beltrán; Germán Bou
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 7.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

Review 8.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 9.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

10.  Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase.

Authors:  Mariano M González; Magda Kosmopoulou; Maria F Mojica; Valerie Castillo; Philip Hinchliffe; Ilaria Pettinati; Jürgen Brem; Christopher J Schofield; Graciela Mahler; Robert A Bonomo; Leticia I Llarrull; James Spencer; Alejandro J Vila
Journal:  ACS Infect Dis       Date:  2015-07-20       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.